BR Biopharma, Inc. (NASDAQ:BRBI) Sees Large Growth in Short Interest

BR Biopharma, Inc. (NASDAQ:BRBI) saw a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 13,657 shares, an increase of 1,264.3% from the October 15th total of 1,001 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 6,646 shares, the days-to-cover ratio is presently 2.1 days.

BR Biopharma Stock Up 25.5%

Shares of BRBI stock traded up $1.86 on Tuesday, hitting $9.18. 327 shares of the stock were exchanged, compared to its average volume of 5,049. The business has a 50-day moving average of $11.43 and a 200 day moving average of $12.52. BR Biopharma has a fifty-two week low of $6.87 and a fifty-two week high of $16.61.

BR Biopharma (NASDAQ:BRBI) last announced its earnings results on Tuesday, November 3rd. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $23.80 million during the quarter.

BR Biopharma Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Monday, November 16th will be paid a dividend of $0.0879 per share. The ex-dividend date of this dividend is Monday, November 16th. This represents a $0.35 annualized dividend and a dividend yield of 3.8%. This is a decrease from BR Biopharma’s previous quarterly dividend of $0.1415. BR Biopharma’s dividend payout ratio (DPR) is 525.00%.

Analysts Set New Price Targets

BRBI has been the subject of several research analyst reports. Citigroup lowered BR Biopharma from a “buy” rating to a “hold” rating in a research report on Tuesday, October 27th. Weiss Ratings upgraded shares of BR Biopharma from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, October 2nd. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, BR Biopharma currently has a consensus rating of “Reduce”.

About BR Biopharma

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.